Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride vs Risperidone for Cognitive Functions in Chronic Schizophrenia
NCT00761670Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amisulpride in schizophrenia, sponsored by Sanofi. Started Sep 2008; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00761670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761670.